-
1
-
-
0024422169
-
Menopause and risk factors for coronary artery disease
-
Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary artery disease. N Engl J Med. 1989;321:1311-1316.
-
(1989)
N Engl J Med
, vol.321
, pp. 1311-1316
-
-
Matthews, K.A.1
Meilahn, E.2
Kuller, L.H.3
Kelsey, S.F.4
Caggiula, A.W.5
Wing, R.R.6
-
3
-
-
0028264285
-
Sex hormones and lipoprotein metabolism
-
Sacks FM, Walsh BW. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol. 1994;5:236-240.
-
(1994)
Curr Opin Lipidol
, vol.5
, pp. 236-240
-
-
Sacks, F.M.1
Walsh, B.W.2
-
4
-
-
0026072558
-
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
-
Walsh BW, Schiff I, Rosner B, Breenberg L, Ravinkar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325: 1196-1204.
-
(1991)
N Engl J Med
, vol.325
, pp. 1196-1204
-
-
Walsh, B.W.1
Schiff, I.2
Rosner, B.3
Breenberg, L.4
Ravinkar, V.5
Sacks, F.M.6
-
5
-
-
77957126077
-
Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
-
published correction appears in JAMA. 1995;274:1676
-
The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial [published correction appears in JAMA. 1995;274:1676]. JAMA. 1995;273:199-208.
-
(1995)
JAMA
, vol.273
, pp. 199-208
-
-
-
6
-
-
0025838806
-
Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
-
Lobb RA. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab. 1991;73:925-930.
-
(1991)
J Clin Endocrinol Metab
, vol.73
, pp. 925-930
-
-
Lobb, R.A.1
-
7
-
-
0025981467
-
Estrogen replacement and coronary heart disease: A quantitative assessment of the epidemiologic evidence
-
Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
-
(1991)
Prev Med
, vol.20
, pp. 47-63
-
-
Stampfer, M.J.1
Colditz, G.A.2
-
8
-
-
0026458371
-
Hormone therapy to prevent disease and prolong life in postmenopausal women
-
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
-
(1992)
Ann Intern Med
, vol.117
, pp. 1016-1037
-
-
Grady, D.1
Rubin, S.M.2
Petitti, D.B.3
Fox, C.S.4
Black, D.5
Ettinger, B.6
Ernster, V.L.7
Cummings, S.R.8
-
9
-
-
0021180802
-
Characterization of lipoprotein particles isolated by immunoaffinity chromatography: Particles containing A-I and A-II and particles containing A-I but no A-II
-
Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem. 1984;259: 12201-12209.
-
(1984)
J Biol Chem
, vol.259
, pp. 12201-12209
-
-
Cheung, M.C.1
Albers, J.J.2
-
10
-
-
0024989085
-
Differential electroimmunoassay of human LP-A-I lipoprotein particles on ready-to-use plates
-
Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LP-A-I lipoprotein particles on ready-to-use plates. Clin Chem. 1990;36:1431-1435.
-
(1990)
Clin Chem
, vol.36
, pp. 1431-1435
-
-
Parra, H.J.1
Mezdour, H.2
Ghalim, N.3
Bard, J.M.4
Fruchart, J.C.5
-
11
-
-
0029866535
-
Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate
-
Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol. 1996;16:431-440.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 431-440
-
-
Brinton, E.A.1
-
12
-
-
0027279942
-
Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
-
Warden CH, Kedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-472.
-
(1993)
Science
, vol.261
, pp. 469-472
-
-
Warden, C.H.1
Kedrick, C.C.2
Qiao, J.H.3
Castellani, L.W.4
Lusis, A.J.5
-
13
-
-
0027373567
-
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
-
Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 1993;365:762-764.
-
(1993)
Nature
, vol.365
, pp. 762-764
-
-
Schultz, J.R.1
Verstuyft, J.G.2
Gong, E.L.3
Nichols, A.V.4
Rubin, E.M.5
-
14
-
-
0025902231
-
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I
-
Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 1991;353:265-267.
-
(1991)
Nature
, vol.353
, pp. 265-267
-
-
Rubin, E.M.1
Krauss, R.M.2
Spangler, E.A.3
Verstuyft, J.G.4
Clift, S.M.5
-
15
-
-
0023261294
-
Apolipoprotein A-I-containing lipoproteins in coronary artery disease
-
Puchois P, Kandoussi A, Fievet P, Fourrier JL, Koren E, Fruchart JC. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 1987;68:35-40.
-
(1987)
Atherosclerosis
, vol.68
, pp. 35-40
-
-
Puchois, P.1
Kandoussi, A.2
Fievet, P.3
Fourrier, J.L.4
Koren, E.5
Fruchart, J.C.6
-
16
-
-
0027331211
-
Parental history of early myocardial infarction is associated with decreased levels of lipoparticle A-I in adolescents
-
Amouyel P, Isorez D, Bard J-M, Goldman M, Lebel P, Zylberberg G, Fruchart JC. Parental history of early myocardial infarction is associated with decreased levels of lipoparticle A-I in adolescents. Arterioscler Thromb. 1993;13:1640-1644.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1640-1644
-
-
Amouyel, P.1
Isorez, D.2
Bard, J.-M.3
Goldman, M.4
Lebel, P.5
Zylberberg, G.6
Fruchart, J.C.7
-
17
-
-
0027330899
-
Familial hypoalphalipoproteinemia in premature coronary artery disease
-
Genest J Jr, Bard JM, Fruchart JC, Ordovas JM, Schaefer EJ. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler Thromb. 1993;13:1728-1737.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1728-1737
-
-
Genest Jr., J.1
Bard, J.M.2
Fruchart, J.C.3
Ordovas, J.M.4
Schaefer, E.J.5
-
18
-
-
0029059943
-
Sex hormones, lipoproteins, and vascular reactivity
-
Sacks FM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol. 1995;6:161-166.
-
(1995)
Curr Opin Lipidol
, vol.6
, pp. 161-166
-
-
Sacks, F.M.1
Gerhard, M.2
Walsh, B.W.3
-
19
-
-
0020510646
-
The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females
-
Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab. 1983;57:262-267.
-
(1983)
J Clin Endocrinol Metab
, vol.57
, pp. 262-267
-
-
Schaefer, E.J.1
Foster, D.M.2
Zech, L.A.3
Lindgren, F.T.4
Brewer Jr., H.B.5
Levy, R.I.6
-
20
-
-
0028033973
-
Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism
-
Walsh BW, Li II, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 1994;35:2083-2093.
-
(1994)
J Lipid Res
, vol.35
, pp. 2083-2093
-
-
Walsh, B.W.1
Li, I.I.2
Sacks, F.M.3
|